KR101767837B1 - Method for producing mixture extract of sea cucumber and sea mustard with enhanced immunity activity - Google Patents
Method for producing mixture extract of sea cucumber and sea mustard with enhanced immunity activity Download PDFInfo
- Publication number
- KR101767837B1 KR101767837B1 KR1020160073615A KR20160073615A KR101767837B1 KR 101767837 B1 KR101767837 B1 KR 101767837B1 KR 1020160073615 A KR1020160073615 A KR 1020160073615A KR 20160073615 A KR20160073615 A KR 20160073615A KR 101767837 B1 KR101767837 B1 KR 101767837B1
- Authority
- KR
- South Korea
- Prior art keywords
- sea cucumber
- sea
- seaweed
- mixed
- present
- Prior art date
Links
- 241000251511 Holothuroidea Species 0.000 title claims abstract description 83
- 239000000284 extract Substances 0.000 title claims abstract description 76
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 26
- 230000036039 immunity Effects 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 title claims description 37
- 235000003351 Brassica cretica Nutrition 0.000 title abstract description 27
- 235000003343 Brassica rupestris Nutrition 0.000 title abstract description 27
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 title abstract description 27
- 235000010460 mustard Nutrition 0.000 title abstract description 27
- 230000000694 effects Effects 0.000 title abstract description 14
- 244000056139 Brassica cretica Species 0.000 title 1
- 239000003674 animal food additive Substances 0.000 claims abstract description 7
- 241001474374 Blennius Species 0.000 claims description 52
- 239000004480 active ingredient Substances 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 230000036541 health Effects 0.000 claims description 13
- 239000011259 mixed solution Substances 0.000 claims description 13
- 235000013376 functional food Nutrition 0.000 claims description 12
- 108091005804 Peptidases Proteins 0.000 claims description 9
- 210000004027 cell Anatomy 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- 102000035195 Peptidases Human genes 0.000 claims description 7
- 108010056079 Subtilisins Proteins 0.000 claims description 7
- 102000005158 Subtilisins Human genes 0.000 claims description 7
- 210000001835 viscera Anatomy 0.000 claims description 6
- 239000004365 Protease Substances 0.000 claims description 4
- 210000000170 cell membrane Anatomy 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 102000004317 Lyases Human genes 0.000 claims description 3
- 108090000856 Lyases Proteins 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 108010003855 mesentericopeptidase Proteins 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 238000012744 immunostaining Methods 0.000 claims 1
- 241000219198 Brassica Species 0.000 abstract description 26
- 235000013305 food Nutrition 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 5
- 230000001900 immune effect Effects 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000007423 decrease Effects 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 208000033065 inborn errors of immunity Diseases 0.000 abstract 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 abstract 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 230000028327 secretion Effects 0.000 description 8
- 210000004988 splenocyte Anatomy 0.000 description 8
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 210000004989 spleen cell Anatomy 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 241000512259 Ascophyllum nodosum Species 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 238000008157 ELISA kit Methods 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 241001261506 Undaria pinnatifida Species 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 230000003308 immunostimulating effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 229920006008 lipopolysaccharide Polymers 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- -1 ring Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 206010062016 Immunosuppression Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- 235000019742 Vitamins premix Nutrition 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 238000011814 C57BL/6N mouse Methods 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 101000648740 Mus musculus Tumor necrosis factor Proteins 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000000185 intracerebroventricular administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/616—Echinodermata, e.g. starfish, sea cucumbers or sea urchins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/202—Algae extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/204—Animal extracts
- A23V2250/2042—Marine animal, fish extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Animal Husbandry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 면역활성이 증진된 해삼 및 미역 혼합추출물의 제조방법에 관한 것이다.The present invention relates to a method for producing sea cucumbers and wakame mixed extracts having enhanced immunological activity.
해삼은 해양수산부가 정한 우리나라 8대 수산물로, 인삼과 같이 사포닌 등의 약효 성분이 다량 함유되어 있어 바다의 인삼으로 불리는 최고의 건강웰빙 보양식품일 뿐만 아니라, 깨끗한 곳에 서식하는 청정 수산물이다. 해삼은 중국에서 산삼으로 여길 만큼 보양식으로 알려져 있으며, 중국을 비롯한 동양에서 예부터 진액을 보하는 약으로서, 당뇨병, 천식 등에 탁월한 효과를 나타내고, 여름에 온도 상승으로 땀을 많이 흘려 기력상실과 허탈 상태에 빠졌을 때 기력을 되찾을 수 있는 약으로 알려져 있다. 또한, 현대과학에 의해 밝혀진 바에 의하면, 해삼에는 단백질과 비타민 B류가 풍부하고, 요오드 성분이 많이 함유되어 있으며, 각종 식품 및 의약품의 원료로 사용되는 콘드로이틴 성분이 다량 함유되어 있다고 알려져 있다. 해삼의 주요성분은 당단백질과 황산콘드로이틴(chondroitin sulphate)이며 당단백질로는 주로 푸코오스(fucose), 글루코오스(glucose), 만누론산(mannuronic acid), N-아세틸글루코사민(N-acetylglucosamine) 등의 다당류로 주로 구성되어 있다. Sea cucumbers are the 8 most important marine products of Korea, as well as ginseng. They are not only the best health and well-being food called sea ginseng, but also a clean aquatic product that lives in a clean place because it contains a lot of active ingredients such as saponin. Sea cucumbers are known to be a herbaceous form as much as wild ginseng in China, and have excellent effects on diabetes and asthma in China and other Asian countries. They have a great effect in summer and a lot of sweat due to temperature rise. It is known as a drug that can regain energy when you fall into it. Also, according to modern science, it is known that sea cucumbers are abundant in protein, vitamin B, iodine, and chondroitin, which are used as raw materials for various foods and medicines. The major components of sea cucumber are glycoprotein and chondroitin sulphate, and glycoproteins are mainly polysaccharides such as fucose, glucose, mannuronic acid and N-acetylglucosamine. .
해조류는 바다에서 나는 조류를 통틀어 지칭하는 것으로, 이러한 해조류는 다시마, 미역, 실말 등의 갈조류와 김, 우뭇가사리 등의 홍조류, 그리고 파래 등의 녹조류 3가지로 구분된다. 우리나라에 서식하는 500여 종 해조류 중 50여 종이 식용으로 이용되고 있으며, 우리나라 사람이 즐겨 먹는 해조류는 미역, 다시마, 김, 파래, 톳, 모자반, 청각 등이다. 한편, 우리나라는 3면이 바다와 접하고 있어서 미역, 다시마, 톳과 같은 해조류의 양식과 자연 채취량은 세계 8위 생산국이다. 해조류는 Ca, P, Mg, Fe, Na, S 등의 원소와 미네랄, 비타민 A, B 및 C로 구성되어 있으며 최근에는 건강 기능성 효과가 밝혀지면서 본격적인 식량자원으로 활용하려는 움직임이 활발해지고 있다. Seaweeds refer to all the birds in the sea, and these seaweeds are divided into three types: brown algae such as kelp, seaweed, and algae, red algae such as seaweed, mugwort, and green algae. Of the 500 species of seaweeds in Korea, about 50 species are used for food. The seaweeds enjoyed by Koreans include seaweed, kelp, kim, paraya, mackerel, mackerel, and hearing. On the other hand, Korea is in contact with the sea on three sides, and seaweeds such as seaweed, kelp, and seaweed are the eighth largest producer in the world. Seaweeds are composed of elements such as Ca, P, Mg, Fe, Na, S and minerals, and vitamins A, B and C. Recently, as health functional effects are revealed,
한편, 한국공개특허 2012-0063709호에는 해삼 추출물을 유효성분으로 포함하는 면역 증강용 조성물에 대해 개시하고 있으며, 한국공개특허 2005-0006533호에는 해조류로부터 항암 및 면역활성 추출물을 추출하는 방법에 대해 개시하고 있다. 하지만, 본 발명의 면역활성이 증진된 해삼 및 미역 혼합추출물의 제조방법에 대해 아직까지 개시한 바가 없다.Korean Patent Publication No. 2012-0063709 discloses a composition for enhancing immunity comprising an extract of sea cucumber as an active ingredient. Korean Patent Laid-Open Publication No. 2005-0006533 discloses a method for extracting an anti-cancer and immunostimulatory extract from seaweed . However, the preparation methods of the sea cucumber and mixed marine wax extracts with improved immunological activity of the present invention have not yet been disclosed.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명에서는 세포막 분해효소 및 단백질 분해효소를 이용하여 해삼 및 미역 혼합추출물을 제조하였으며, 본 발명의 해삼 및 미역 혼합추출물이 기존에 면역활성이 있다고 알려진 해삼 추출물 및 미역 추출물 각각 보다 면역활성이 더 우수한 것을 확인함으로써, 본 발명을 완성하였다.The present invention has been made in view of the above-mentioned needs. In the present invention, mixed sea cucumber and sea mustard extracts were prepared using cell membrane degrading enzymes and proteolytic enzymes, and the sea cucumber and sea mustard mixed extracts of the present invention had immunological activity The present inventors have completed the present invention by confirming that the sea cucumber extract and the seaweed extract are superior to each other in immunity.
상기 과제를 해결하기 위하여, 본 발명은 1) 내장을 제거하고 100℃ 이상의 온도에서 삶은 해삼과 세척한 미역을 건조하는 단계; 2) 상기 단계 1)에서 건조한 해삼 및 미역을 혼합하여 분쇄한 후 물을 첨가하여 혼합용액을 제조하는 단계; 3) 상기 단계 2)의 혼합용액에 세포막 분해효소 및 단백질 분해효소를 첨가하는 단계; 및 4) 상기 세포막 분해효소 및 단백질 분해효소가 첨가된 혼합용액을 효소반응기에 넣어 100~140℃에서 15~35분간 멸균한 후 40~65℃에서 15~30시간 정도 유지하는 단계를 포함하는 면역활성이 증진된 해삼 및 미역 혼합추출물의 제조방법을 제공한다.In order to solve the above-described problems, the present invention provides a method for preparing a sea cucumber, comprising the steps of: 1) removing the viscera and drying the sea cucumber washed with boiled sea cucumber at a temperature of 100 ° C or higher; 2) mixing the dried sea cucumber and the seaweed in step 1), pulverizing and adding water to prepare a mixed solution; 3) adding a cell membrane-degrading enzyme and a proteolytic enzyme to the mixed solution of step 2); And 4) adding the cell membrane lyase and protease-added mixed solution to an enzyme reactor, sterilizing the mixture at 100 to 140 ° C for 15 to 35 minutes, and then maintaining the mixture at 40 to 65 ° C for 15 to 30 hours The present invention provides a method for preparing sea cucumbers and seaweed mixed extracts with enhanced activity.
또한, 본 발명은 상기 방법으로 제조된 해삼 및 미역 혼합추출물을 제공한다.The present invention also provides sea cucumber and wakame mixed extracts prepared by the above method.
또한, 본 발명은 상기 해삼 및 미역 혼합추출물을 유효성분으로 함유하는 면역증강용 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition for immune enhancement comprising the sea cucumber and the seaweed mixed extract as an active ingredient.
또한, 본 발명은 상기 해삼 및 미역 혼합추출물을 유효성분으로 함유하는 면역증강용 약학조성물을 제공한다.In addition, the present invention provides a pharmaceutical composition for enhancing immunity, comprising the sea cucumber and the seaweed mixed extract as an active ingredient.
또한, 본 발명은 상기 해삼 및 미역 혼합추출물을 유효성분으로 함유하는 면역증강용 사료첨가제 조성물을 제공한다.In addition, the present invention provides a feed additive composition for immunity enhancement comprising the sea cucumbers and the seaweed mixed extract as an active ingredient.
본 발명의 해삼 및 미역 혼합추출물은 면역활성이 우수하므로, 면역 저하 및 면역계가 손상된 면역저하증의 예방, 억제 또는 치료에 우수한 면역증강 효능을 갖는 식품, 의약품 또는 사료첨가제로 이용될 수 있다.Since the sea cucumber and the seaweed mixed extract of the present invention have excellent immunity, they can be used as foods, medicines or feed additives having immunity enhancing effect for preventing, inhibiting or treating immunosuppression and immunosuppressed immunosuppression.
도 1은 본 발명의 해삼 및 미역 혼합추출물을 처리하였을 때, RAW264.7 세포에서 NO 생성(A) 및 TNF-α(B)의 분비 증가 효과를 나타낸 것이다. C는 아무것도 처리하지 않은 음성 대조군이며, LPS(Lipopolysaccharide)는 양성 대조군이다.
도 2는 본 발명의 해삼 및 미역 혼합추출물을 처리하였을 때, 비장세포의 IFN-γ(A) 및 TNF-α(B) 생성 증가 효과를 나타낸 것이다. media는 배지만을 처리한 음성 대조군이다.FIG. 1 shows the effect of increasing the secretion of NO production (A) and TNF-α (B) in RAW264.7 cells when the sea cucumber and the seaweed mixed extract of the present invention were treated. C is a negative control without any treatment, and LPS (Lipopolysaccharide) is a positive control.
FIG. 2 shows the effect of increasing the production of IFN-? (A) and TNF-? (B) in splenocytes when the sea cucumber and the seaweed mixed extract of the present invention were treated. The media is a negative control that processed the bait.
본 발명을 달성하기 위하여, 본 발명은 1) 내장을 제거하고 100℃ 이상의 온도에서 삶은 해삼과 세척한 미역을 건조하는 단계;In order to accomplish the present invention, the present invention provides a method for producing sea cucumbers, comprising the steps of: 1) removing the viscera and drying seaweed washed with boiled sea cucumber at a temperature of 100 ° C or higher;
2) 상기 단계 1)에서 건조한 해삼 및 미역을 혼합하여 분쇄한 후 물을 첨가하여 혼합용액을 제조하는 단계;2) mixing the dried sea cucumber and the seaweed in step 1), pulverizing and adding water to prepare a mixed solution;
3) 상기 단계 2)의 혼합용액에 세포막 분해효소 및 단백질 분해효소를 첨가하는 단계; 및3) adding a cell membrane-degrading enzyme and a proteolytic enzyme to the mixed solution of step 2); And
4) 상기 세포막 분해효소 및 단백질 분해효소가 첨가된 혼합용액을 효소반응기에 넣어 100~140℃에서 15~35분간 멸균한 후 40~65℃에서 15~30시간 정도 유지하는 단계를 포함하는 면역활성이 증진된 해삼 및 미역 혼합추출물의 제조방법을 제공한다.4) immersing the mixed solution containing the cell membrane lyase and protease into an enzyme reactor, sterilizing the mixture at 100 to 140 ° C for 15 to 35 minutes, and maintaining the mixture at 40 to 65 ° C for 15 to 30 hours And a method for producing the enhanced sea cucumber and the seaweed mixed extract.
본 발명의 일 구현 예에 따른 제조방법에서, 상기 단계 1)에서 해삼을 삶는 온도는 100℃ 이상, 바람직하게는 100~130℃일 수 있으나, 이에 제한되지 않는다.In the production method according to an embodiment of the present invention, the temperature at which the sea cucumber is boiled in the step 1) may be 100 ° C. or higher, preferably 100 to 130 ° C., but is not limited thereto.
본 발명의 일 구현 예에 따른 제조방법에서, 상기 단계 3)에서 세포막 분해효소는 투니카아제(tunicase)이며, 단백질 분해효소는 알칼라아제(alcalase) 또는 에스퍼라아제(esperase)일 수 있으며, 바람직하게는 단백질 분해효소는 알칼라아제(alcalase)일 수 있으나, 이에 제한되지 않는다.In the production method according to an embodiment of the present invention, the cell membrane-degrading enzyme in step 3) may be tunicase, the protease may be alcalase or esperase, Preferably, the proteolytic enzyme may be, but not limited to, an alcalase.
또한, 상기 단계 4)의 혼합용액은 100~140℃에서 15~35분간 멸균한 후 40~65℃에서 15~30시간 정도 유지하는 단계를 포함하는 것일 수 있으며, 바람직하게는 130℃에서 30분간 멸균한 후 60℃에서 24시간 정도 유지하는 단계를 포함하는 것일 수 있으나, 이에 제한되지 않는다.In addition, the mixed solution of step 4) may be sterilized at 100 to 140 ° C for 15 to 35 minutes and then maintained at 40 to 65 ° C for 15 to 30 hours, preferably at 130 ° C for 30 minutes Followed by maintaining at 60 ° C for about 24 hours after sterilization, but the present invention is not limited thereto.
또한, 본 발명은 상기 방법으로 제조된 해삼 및 미역 혼합추출물을 제공한다.The present invention also provides sea cucumber and wakame mixed extracts prepared by the above method.
본 발명의 해삼 및 미역 혼합추출물은 추출처리에 의해 얻어지는 추출액, 추출액의 희석액 또는 농축액, 추출액을 건조하여 얻어지는 건조물, 조정제물 또는 정제물 중 어느 하나를 포함하는 것으로 한다.The sea cucumber and the seaweed mixed extract of the present invention include any one of an extract obtained by an extraction treatment, a diluted or concentrated liquid of an extract, a dried product obtained by drying an extract, a preparation to be treated, or a purified product.
또한, 본 발명은 상기 해삼 및 미역 혼합추출물을 유효성분으로 함유하는 면역증강용 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition for immune enhancement comprising the sea cucumber and the seaweed mixed extract as an active ingredient.
본 발명의 면역증강용 건강기능식품 조성물은 분말, 과립, 환, 정제, 캡슐, 캔디, 시럽 및 음료 중에서 선택된 어느 하나의 제형으로 제조될 수 있으나, 이에 제한되지 않는다.The immunocompromising health functional food composition of the present invention may be prepared in any form of powder, granule, ring, tablet, capsule, candy, syrup and beverage, but is not limited thereto.
본 발명의 건강기능식품 조성물을 식품첨가물로 사용하는 경우, 상기 건강기능식품 조성물을 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분은 그의 사용 목적(예방 또는 개선)에 따라 적절하게 사용될 수 있다. 일반적으로, 식품 또는 음료의 제조시 본 발명의 건강기능식품 조성물에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양으로 첨가된다. 그러나 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로 사용될 수 있다.When the health functional food composition of the present invention is used as a food additive, the health functional food composition may be added as it is, or may be used together with other food or food ingredients, and suitably used according to a conventional method. The active ingredient may be suitably used depending on its intended use (prevention or improvement). Generally, in the production of food or beverage, it is added in an amount of not more than 15 parts by weight, preferably not more than 10 parts by weight, based on the health functional food composition of the present invention. However, in the case of long-term intake for the purpose of controlling health, the amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount exceeding the above range.
상기 식품의 종류에는 특별한 제한은 없다. 상기 건강기능식품 조성물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the kind of the food. Examples of the foods to which the health functional food composition can be added include dairy products including meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen and other noodles, gums, ice cream, soups, Drinks, alcoholic beverages, and vitamin complexes, all of which include health foods in a conventional sense.
또한, 본 발명의 건강기능식품 조성물은 식품, 특히 기능성 식품으로 제조될 수 있다. 본 발명의 기능성 식품은 식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함시킬 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등), 디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등) 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다.In addition, the health functional food composition of the present invention can be produced as a food, particularly a functional food. The functional food of the present invention includes components that are ordinarily added in food production, and includes, for example, proteins, carbohydrates, fats, nutrients, and seasonings. For example, in the case of a drink, a natural carbohydrate or a flavoring agent may be included as an additional ingredient in addition to the active ingredient. The natural carbohydrate may be selected from the group consisting of monosaccharides (e.g., glucose, fructose, etc.), disaccharides (e.g., maltose, sucrose etc.), oligosaccharides, polysaccharides (e.g., dextrin, cyclodextrin, , Xylitol, sorbitol, erythritol, etc.). The flavoring agent may be a natural flavoring agent (e.g., tau Martin, stevia extract, etc.) and a synthetic flavoring agent (e.g., saccharin, aspartame, etc.).
상기 건강기능식품 조성물 외에 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. In addition to the above-mentioned health functional food composition, it is possible to use various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and salts thereof, alginic acid and its salts, organic acids, protective colloid thickening agents, pH adjusting agents, stabilizers, preservatives, glycerin, A carbonating agent used in beverages, and the like.
또한, 본 발명은 상기 해삼 및 미역 혼합추출물을 유효성분으로 함유하는 면역증강용 약학조성물을 제공한다.In addition, the present invention provides a pharmaceutical composition for enhancing immunity, comprising the sea cucumber and the seaweed mixed extract as an active ingredient.
본 발명의 약학 조성물은 약학적 조성물의 제조에 통상적으로 사용하는 적절한 담체, 부형제 및 희석제를 더 포함할 수 있다.The pharmaceutical compositions of the present invention may further comprise suitable carriers, excipients and diluents conventionally used in the manufacture of pharmaceutical compositions.
본 발명에 따른 조성물의 약학적 투여 형태는 단독으로 또는 타 약학적 활성 화합물과 결합뿐만 아니라 적당한 집합으로 사용될 수 있다.The pharmaceutical dosage forms of the compositions according to the invention may be used alone or in combination with other pharmaceutically active compounds as well as in a suitable set.
본 발명에 따른 약학 조성물은, 각각 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제형, 외용제, 좌제 및 멸균 주사용액의 형태로 제형화하여 사용될 수 있다. 상기 해삼 및 미역 혼합추출물을 포함하는 약학 조성물에 포함될 수 있는 담체, 부형제 및 희석제로는 락토즈, 덱스트로즈, 수크로스, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로오스, 메틸 셀룰로오스, 미정질 셀룰로오스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유 등을 포함한 다양한 화합물 혹은 혼합물을 들 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구 투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 해삼 및 미역 혼합추출물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트, 수크로오스 또는 락토오스, 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순 희석제인 물, 리퀴드 파라핀 이 외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜, 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔, 마크로골, 트윈 61, 카카오지, 라우린지, 글리세로젤라틴 등이 사용될 수 있다.The pharmaceutical composition according to the present invention may be formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols and the like, oral preparations, suppositories and sterilized injection solutions according to a conventional method . Examples of carriers, excipients and diluents that can be included in the pharmaceutical composition including the sea cucumber and the sea mustard mixed extract include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin , Calcium phosphate, calcium silicate, cellulose, methylcellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil, etc. . In the case of formulation, a diluent or excipient such as a filler, an extender, a binder, a wetting agent, a disintegrant, or a surfactant is usually used. Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain at least one excipient such as starch, calcium carbonate, sucrose or lactose, Gelatin and the like. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used. Examples of liquid formulations for oral use include suspensions, solutions, emulsions and syrups. In addition to water and liquid paraffin, which are commonly used simple diluents, various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like have. Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Examples of the suspending agent include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like. Examples of the suppository base include withexol, macrogol, tween 61, cacao butter, laurin, glycerogelatin and the like.
본 발명의 약학 조성물의 바람직한 투여량은 환자의 상태 및 체중, 질병의 정도, 약물형태, 투여경로 및 기간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다. The preferred dosage of the pharmaceutical composition of the present invention varies depending on the condition and the weight of the patient, the degree of disease, the drug form, the administration route and the period, but can be appropriately selected by those skilled in the art.
본 발명의 해삼 및 미역 혼합추출물은 쥐, 생쥐, 가축, 인간 등의 포유동물에 다양한 경로로 투여될 수 있다. 투여의 모든 방식은 예상될 수 있는데, 예를 들면, 경구, 직장 또는 정맥, 근육, 피하, 자궁 내 경막 또는 뇌혈관 내(intracerebroventricular) 주사에 의해 투여될 수 있다.The sea cucumber and marrow mixed extract of the present invention can be administered to mammals such as rats, mice, livestock, and humans in various routes. All modes of administration may be expected, for example, by oral, rectal or intravenous, intramuscular, subcutaneous, intra-uterine or intracerebroventricular injections.
또한, 본 발명은 상기 해삼 및 미역 혼합추출물을 유효성분으로 함유하는 면역증강용 사료첨가제 조성물을 제공한다.In addition, the present invention provides a feed additive composition for immunity enhancement comprising the sea cucumbers and the seaweed mixed extract as an active ingredient.
본 발명의 사료 첨가제는 기초사료에 일정 비율로 첨가하는 것이다. 상기 기초사료는 주성분이 옥수수, 대두박, 유청, 어분, 당밀, 소금, 비타민 프리믹스 및 미네랄 프리믹스 등으로 이루어질 수 있다. 비타민 프리믹스는 비타민 A, 비타민 D, 비타민 E, 리보프라빈 및 나이아신으로 구성될 수 있으며, 미네랄 프리믹스는 망간, 철, 아연, 칼슘, 구리, 코발트 및 셀레니늄 등으로 구성될 수 있다.The feed additive of the present invention is added to the base feed at a certain ratio. The basic diet may be composed of corn, soybean meal, whey, fish meal, molasses, salt, vitamin premix, and mineral premix. The vitamin premix can be composed of vitamin A, vitamin D, vitamin E, riboflavin and niacin, and the mineral premix can be composed of manganese, iron, zinc, calcium, copper, cobalt and selenium.
본 발명의 면역 증강용 사료첨가제를 포함하는 사료 조성물은 기술분야에 공지된 사료 제조방법에 따라 제조될 수 있으며, 예를 들어, 각종 사료 원료 또는 배합사료와 본 발명의 해삼 및 미역 혼합추출물을 혼합한 후, 추가적인 가공 공정, 예를 들어 펠렛 형태로의 성형 또는 과립 등의 형태로의 절단 단계 등을 더 수행함으로써 제조될 수 있다.The feed composition comprising the immunostimulating feed additive of the present invention can be prepared according to a feed production method known in the art. For example, various feed ingredients or compound feeds can be mixed with sea cucumber and sea weed mixed extract of the present invention Followed by further processing, for example, pelleting, or cutting in the form of granules, and the like.
본 발명의 면역 증강용 사료 조성물의 구성성분, 조성, 제조방법, 급여방법 등은 기술분야에 공지된 통상의 기술로부터 적절히 선택될 수 있음이 통상의 기술자에게 명백하다.It is apparent to those skilled in the art that the composition, composition, manufacturing method, feeding method and the like of the immunostimulating feed composition of the present invention can be suitably selected from conventional techniques known in the art.
이하, 실시예를 이용하여 본 발명을 더욱 상세하게 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 당해 기술분야에서 통상의 지식을 가진 자에게 있어 자명한 것이다. Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are merely illustrative of the present invention and that the scope of the present invention is not limited thereto.
제조예Manufacturing example 1. 해삼 추출물 및 미역 추출물의 제조 1. Preparation of sea cucumber extracts and sea mustard extracts
내장을 제거하고 100℃ 이상의 온도에서 삶은 해삼과 세척한 미역을 건조하였으며, 건조한 해삼 40g 및 미역 40g을 각각 5mm 이하로 분쇄하여 각각에 58ml의 정제수, 투니카아제(tunicase) 1g 및 알칼라아제(alcalase) 1g을 첨가한 후, 이를 효소반응기에 넣어 110℃에서 20분간 멸균한 뒤 45℃에서 24시간 유지하여 해삼 추출물 및 미역 추출물을 각각 수득하였으며, 100 메쉬의 체에 고형분을 걸러 낸 후 하기 실시예에 사용하였다.Dried seaweed 40g and sea mustard 40g were crushed to a size of 5mm or less, respectively, and to each were added 58ml of purified water, 1g of tunicase, and 1g of alkalase ( alcalase) was added thereto, and the resulting mixture was placed in an enzyme reactor and sterilized at 110 ° C for 20 minutes. Then, the mixture was kept at 45 ° C for 24 hours to obtain a sea cucumber extract and a sea mustard extract. Solid components were filtered through a 100 mesh sieve, For example.
제조예Manufacturing example 2. 해삼 및 미역 혼합추출물 1의 제조 2. Preparation of sea cucumber and sea mustard mixed extract 1
내장을 제거하고 100℃ 이상의 온도에서 삶은 해삼과 세척한 미역을 건조하였으며, 건조한 해삼 20g 및 미역 20g을 혼합하여 5mm 이하로 분쇄한 후 58ml의 정제수를 첨가하여 혼합용액을 제조하였다. 여기에 투니카아제(tunicase) 1g 및 알칼라아제(alcalase) 1g을 첨가하고, 이를 효소반응기에 넣어 110℃에서 20분간 멸균한 뒤 45℃에서 24시간 유지하여 해삼 및 미역 혼합추출물을 수득하였으며, 100 메쉬의 체에 고형분을 걸러 낸 후 하기 실시예에 사용하였다.After removing the viscera, sea cucumbers washed with boiled sea cucumber were dried at a temperature of 100 ° C or higher. 20 g of dried sea cucumber and 20 g of seaweed were mixed and pulverized to 5 mm or less, and 58 ml of purified water was added to prepare a mixed solution. 1 g of tunicase and 1 g of alcalase were added thereto and sterilized at 110 ° C for 20 minutes in an enzyme reactor. The mixture was kept at 45 ° C for 24 hours to obtain a mixed extract of sea cucumber and sea mustard, A solid of 100 mesh was sieved and used in the following examples.
제조예Manufacturing example 3. 해삼 및 미역 혼합추출물 2의 제조 3. Preparation of sea cucumber and sea mustard mixed extract 2
내장을 제거하고 100℃ 이상의 온도에서 삶은 해삼과 세척한 미역을 건조하였으며, 건조한 해삼 25g 및 미역 20g을 혼합하여 5mm 이하로 분쇄한 후 51ml의 정제수를 첨가하여 혼합용액을 제조하였다. 여기에 투니카아제(tunicase) 2g 및 알칼라아제(alcalase) 2g을 첨가하고, 이를 효소반응기에 넣어 110℃에서 20분간 멸균한 뒤 45℃에서 24시간 유지하여 해삼 및 미역 혼합추출물을 수득하였으며, 100 메쉬의 체에 고형분을 걸러 낸 후 하기 실시예에 사용하였다.After removing the viscera, the seaweed washed with boiled sea cucumber was dried at a temperature of 100 ° C or higher. 25 g of dried sea cucumber and 20 g of seaweed were mixed and pulverized to 5 mm or less, and 51 ml of purified water was added to prepare a mixed solution. 2 g of tunicase and 2 g of alcalase were added thereto and sterilized at 110 ° C. for 20 minutes in an enzyme reactor. The mixture was kept at 45 ° C. for 24 hours to obtain a mixed extract of sea cucumber and sea mustard, A solid of 100 mesh was sieved and used in the following examples.
제조예Manufacturing example 4. 해삼 및 미역 혼합추출물 3의 제조 4. Preparation of sea cucumber and sea mustard mixed extract 3
내장을 제거하고 100℃ 이상의 온도에서 삶은 해삼과 세척한 미역을 건조하였으며, 건조한 해삼 25g 및 미역 15g을 혼합하여 5mm 이하로 분쇄한 후 50ml의 정제수를 첨가하여 혼합용액을 제조하였다. 여기에 투니카아제(tunicase) 5g 및 알칼라아제(alcalase) 5g을 첨가하고, 이를 효소반응기에 넣어 130℃에서 30분간 멸균한 뒤 60℃에서 24시간 유지하여 해삼 및 미역 혼합추출물을 수득하였으며, 100 메쉬의 체에 고형분을 걸러 낸 후 하기 실시예에 사용하였다.After removing the viscera, the seaweed washed with boiled sea cucumber was dried at a temperature of 100 ° C or higher. 25 g of dried sea cucumber and 15 g of seaweed were mixed and pulverized to 5 mm or less, and 50 ml of purified water was added to prepare a mixed solution. 5 g of tunicase and 5 g of alcalase were added thereto and sterilized at 130 ° C. for 30 minutes in an enzyme reactor. The mixture was kept at 60 ° C. for 24 hours to obtain a mixed extract of sea cucumber and sea mustard, A solid of 100 mesh was sieved and used in the following examples.
실시예Example 1. 해삼 및 미역 혼합추출물의 NO 분비 및 1. NO secretion of sea cucumber and marine mixed extract and TNFTNF -α 분비의 증가 효과Increased effect of -α secretion
NO 분비효과를 측정하기 위하여 아질산 이온(NO2 -)의 농도는 NaNO2를 기준으로 그리스 시약(Griess reagent)을 이용하여 발색정도를 하기와 같이 측정하였다. RAW264.7 세포(ATCC The Global Bioresource CenterTM)를 96 웰 마이크로플레이트에 웰 당 1×105씩 분주하고, 각각 100㎍/㎖ 농도의 해삼 추출물과 미역 추출물 및 100㎍/㎖ 농도로 상기 제조예 2 내지 4에서 수득한 해삼과 미역 혼합추출물을 처리한 후, 37℃ 및 5% CO2 조건에서 24시간 배양한 후, 상층액을 취하여, 100㎕의 세포 배양 상층액에 동량의 그리스 시약(Griess reagent, 0.1%(w/v)N-(1-naphthyl)ethylenediamine dihydrochloride + 1% (w/v) sulfanilamide in 5%(v/v)phosphoric acid)을 넣고 혼합한 다음, 상온에서 10분 두었으며, 그 후 울트로스펙 4000 스펙트로포토메터 (Pharmacia Biotech사, Uppsala, Sweden)를 사용하여 550nm에서 흡광도를 측정하였다. 또한, 같은 조건에서 50㎕의 세포 배양 상층액을 취하여 염증 매개물질(inflammatory mediator)인 TNF-α(tumor necrosis factor-α)의 ELISA 검사를 실시하였다. In order to measure NO secretion effect, the concentration of nitrite ion (NO 2 - ) was measured by using a grease reagent based on NaNO 2 as follows. RAW264.7 cells (ATCC The Global Bioresource Center TM) for the manufacture of 96-well micro-plate per well in 1 division, and by × 10 5, respectively 100㎍ / ㎖ concentration of sea cucumber extract, seaweed extract, and 100㎍ / ㎖ concentration Yes After culturing the mixture of sea cucumber and sea mustard extracts obtained in 2 to 4 at 37 ° C and 5% CO 2 for 24 hours, the supernatant was taken, and 100 μl of the cell culture supernatant was mixed with the same amount of grease 1% (w / v) sulfanilamide in 5% (v / v) phosphoric acid) was added to each well and incubated at room temperature for 10 minutes. , And then absorbance was measured at 550
그 결과, 도 1에 개시한 바와 같이 RAW264.7 세포에서 본 발명의 해삼 및 미역 혼합추출물 처리시 산화질소(NO)의 농도가 해삼 및 미역 추출물을 각각 처리한 대조군 대비 약 1.7배 증가하였고, 이를 통해 해삼 및 미역 혼합추출물이 NO 분비를 증가시킴을 확인할 수 있었으며, 또한, RAW264.7 세포에서 본 발명의 해삼 및 미역 혼합추출물 처리시 염증 매개물질(inflammatory mediator)인 TNF-α가 해삼 및 미역 추출물을 각각 처리한 대조군 대비 약 1.6배 증가하여, 양성대조군으로 사용한 LPS 단독 처리군과 유사한 증가효과를 나타냄에 따라, 해삼 및 미역 혼합추출물은 TNF-α와 NO 분비를 모두 증가시킴을 확인할 수 있었다.As a result, as shown in FIG. 1, the concentration of nitric oxide (NO) in the RAW 264.7 cells treated with the sea cucumber and the marine mixed extract of the present invention increased about 1.7 times as compared with the control group treated with sea cucumber and sea mustard extracts, In addition, TNF-α, an inflammatory mediator in the treatment of mixed sea cucumber and sea mustard extracts of RAW264.7 cells, was found to inhibit the secretion of sea cucumber and sea mustard extracts And the increase in the secretion of TNF-α and NO in the sea cucumbers and seaweed mixed extracts was increased by the similar increase of the LPS-treated group to that of the control group.
실시예Example 2. 해삼 및 미역 혼합추출물의 2. A mixture of sea cucumber and sea mustard mixed extract 비장세포Splenocyte 증식 효과 Proliferation effect
해삼 및 미역 혼합추출물이 세포 증식에 영향을 주는지 알아보기 위해 C57BL/6N 마우스로부터 비장을 취하여 분별하지 않은 비장세포를 분리한 다음, 96 웰 마이크로 플레이트에 1×106 비장세포를 분주하였다. 각각 100㎍/㎖ 농도의 해삼 추출물과 미역 추출물 및 100㎍/㎖ 농도로 상기 제조예 2 내지 4에서 수득한 해삼과 미역 혼합추출물을 24시간 동안 처리하고 MTS 방법(CellTiter96™ AQueous Assay)을 통해 세포증식을 측정하였다. 그 결과, 하기 표 1에서 개시한 바와 같이 대조군(해삼 및 미역 추출물을 각각 처리한 군)보다 해삼 및 미역 혼합추출물을 처리한 군(제조예 2 내지 4)에서 탁월한 세포증식 효과를 나타내었으므로, 해삼 및 미역 혼합추출물이 비장세포의 증식을 유도함을 확인할 수 있었다.To determine whether the sea cucumber and sea mustard mixed extracts affected cell proliferation, splenocytes were isolated from C57BL / 6N mice to separate non-sorted spleen cells, and then 1 × 10 6 spleen cells were dispensed into 96-well microplates. The sea cucumber extracts and the seaweed extracts at a concentration of 100 μg / ml and the seaweed extracts obtained in the above Preparation Examples 2 to 4 were treated for 24 hours at a concentration of 100 μg / ml, respectively, and cultured for 24 hours using the MTS method (CellTiter96 ™ AQueous Assay) Proliferation was measured. As a result, as shown in the following Table 1, the cell proliferation effect was excellent in the group treated with the sea cucumber and sea mustard mixed extracts (Production Examples 2 to 4) than the control group (the group treated with the sea cucumber and the sea mustard extracts respectively) It was confirmed that the sea cucumber and the seaweed mixed extract induce the proliferation of spleen cells.
contorl(%)
contorl (%)
해삼 추출물
Sea cucumber extract
미역 추출물
Seaweed extract
실시예Example 3. 해삼 및 미역 혼합추출물의 3. A mixture of sea cucumber and sea mustard mixed extract 비장세포에서In splenocytes 사이토카인 발현 증가 효과 Increased effect of cytokine expression
해삼 및 미역 혼합추출물이 비장세포(splenocyte)로부터 분비되는 TH1 사이토카인(cytokine) 생성에 영향을 주는지 알아보기 위해, 마우스로부터 비장을 취하여 분별하지 않은 비장세포를 분리한 다음, 96 웰 마이크로 플레이트에 1×106 비장세포를 분주하였다. 각각 100㎍/㎖ 농도의 해삼 추출물과 미역 추출물 및 100㎍/㎖ 농도로 상기 제조예 2 내지 4에서 수득한 해삼과 미역 혼합추출물을 24시간 동안 처리하고, IFN-γ ELISA 키트(mouse IFN-γ ELISA kit, BD) 및 TNF-α ELISA 키트(Quantikine Mouse TNF-α/TNFSF1A kit, R&D Systems)를 이용하여 사이토카인(cytokine) 분비 정도를 측정하였다. 그 결과, 도 2에서 개시한 바와 같이 해삼 및 미역 추출물을 각각 처리한 대조군과 비교하여 해삼 및 미역 혼합추출물을 처리한 군에서 IFN-γ 및 TNF-α 분비능이 더 증가한 것을 확인할 수 있었다.To determine whether the sea cucumbers and seaweed mixed extracts affect the production of T H 1 cytokines secreted from splenocytes, spleens were taken from the mice to separate non-sorted spleen cells and then seeded in 96-well microplates Lt; 6 > splenocytes. The sea cucumber extracts and the seaweed extracts at a concentration of 100 μg / ml and the seaweed extracts obtained in the above Preparation Examples 2 to 4 were treated for 24 hours at a concentration of 100 μg / ml, respectively, and IFN-γ ELISA kit (mouse IFN- The cytokine secretion level was measured using an ELISA kit (BD) and a TNF-α ELISA kit (Quantikine Mouse TNF-α / TNFSF1A kit, R & D Systems). As a result, it was confirmed that IFN-y and TNF-a secretion potency was further increased in the group treated with sea cucumber and sea mustard mixed extracts as compared with the control group treated with sea cucumber and sea mustard extracts, respectively, as shown in Fig.
Claims (6)
2) 상기 단계 1)에서 건조한 해삼 및 미역을 혼합하여 분쇄한 후 물을 첨가하여 혼합용액을 제조하는 단계;
3) 상기 단계 2)의 혼합용액에 세포막 분해효소 및 단백질 분해효소를 첨가하는 단계; 및
4) 상기 세포막 분해효소 및 단백질 분해효소가 첨가된 혼합용액을 효소반응기에 넣어 100~140℃에서 15~35분간 멸균한 후 40~65℃에서 15~30시간 정도 유지하는 단계를 포함하는 면역활성이 증진된 해삼 및 미역 혼합추출물의 제조방법.1) removing the viscera and drying the sea cucumber and the washed seaweed at a temperature of 100 ° C or higher;
2) mixing the dried sea cucumber and the seaweed in step 1), pulverizing and adding water to prepare a mixed solution;
3) adding a cell membrane-degrading enzyme and a proteolytic enzyme to the mixed solution of step 2); And
4) immersing the mixed solution containing the cell membrane lyase and protease into an enzyme reactor, sterilizing the mixture at 100 to 140 ° C for 15 to 35 minutes, and maintaining the mixture at 40 to 65 ° C for 15 to 30 hours And a method for producing the sea cucumber and marrow mixed extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160073615A KR101767837B1 (en) | 2016-06-14 | 2016-06-14 | Method for producing mixture extract of sea cucumber and sea mustard with enhanced immunity activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160073615A KR101767837B1 (en) | 2016-06-14 | 2016-06-14 | Method for producing mixture extract of sea cucumber and sea mustard with enhanced immunity activity |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101767837B1 true KR101767837B1 (en) | 2017-08-14 |
Family
ID=60142102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160073615A KR101767837B1 (en) | 2016-06-14 | 2016-06-14 | Method for producing mixture extract of sea cucumber and sea mustard with enhanced immunity activity |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101767837B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220133454A (en) * | 2021-03-25 | 2022-10-05 | (주) 아이투디 | A composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract for improvement of immunity |
KR102540314B1 (en) * | 2022-04-07 | 2023-06-08 | 어업회사법인 두비 주식회사 | Feed additive composition for pet containing sea cucumber as main component |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100397531B1 (en) | 2000-07-26 | 2003-09-13 | 주식회사 선진애드 | Brown seaweed extract product having immuno-enhancement activity and methods of producing and utilizing the same |
-
2016
- 2016-06-14 KR KR1020160073615A patent/KR101767837B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100397531B1 (en) | 2000-07-26 | 2003-09-13 | 주식회사 선진애드 | Brown seaweed extract product having immuno-enhancement activity and methods of producing and utilizing the same |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220133454A (en) * | 2021-03-25 | 2022-10-05 | (주) 아이투디 | A composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract for improvement of immunity |
KR102643524B1 (en) * | 2021-03-25 | 2024-04-02 | 사단법인 약용작물산업화기술연구소 | A composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract for improvement of immunity |
KR102540314B1 (en) * | 2022-04-07 | 2023-06-08 | 어업회사법인 두비 주식회사 | Feed additive composition for pet containing sea cucumber as main component |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101705548B1 (en) | Composition for enhancing immune response comprising extract of Apios americana Medikus or fermented extract of the same | |
KR101767837B1 (en) | Method for producing mixture extract of sea cucumber and sea mustard with enhanced immunity activity | |
KR102249652B1 (en) | Composition for prevention or treatment of inflammatory Bowel Disease comprising exosome from Giardia lamblia | |
KR101620275B1 (en) | Brown algae-derived mixed composition and preparation method thereof | |
KR101396134B1 (en) | Composition containing Cornus fruit extracts, fractions thereof or compounds isolated therefrom for prevention or treatment of colitis | |
KR101604448B1 (en) | Pharmaceutical composition for antiinflammatory and preventing or treating immune disease comprising extract of black rice bran | |
KR101843280B1 (en) | Food composition for immune enhancement comprising enzymatic hydrolysate of tuna cooking drip as active ingredient | |
KR101494664B1 (en) | fermented corni fructus composition with antioxidant activity and method of making the same | |
KR101561648B1 (en) | Immuno-stimulating activities of polysaccharide fractions isolated from citrus peel, preparing method thereof and health functional food comprising the the same | |
KR20170047546A (en) | A antibiotic composition for Helicobacter pylori containing the purified honey | |
KR101466308B1 (en) | Composition containing Anemarrhena asphodeloides Bunge extracts, fractions thereof or compounds isolated therefrom for prevention or treatment of colitis | |
JP5892436B2 (en) | Antihypertensive | |
KR101790657B1 (en) | Extraction of polysaccharides from pine nut cake and composition comprising pine nut extract for enhancement of immunity | |
KR102312675B1 (en) | A composition for improving, preventing and treating of anti-inflammatory, obesity and nonalcoholic fatty liver disease comprising Artemisia Annua extract, Magnolia Obovata Bark extract and its mixed extracts | |
KR101084939B1 (en) | Composition comprising the extract of sea algae for preventing and treating hypertension | |
KR101420268B1 (en) | Composition containing Galla rhois extracts, fractions thereof or compounds isolated therefrom for prevention or treatment of colitis | |
KR20220160159A (en) | Method for producing mixture extract of sea cucumber, ginseng and seaweed with enhanced immunity activity | |
KR20200131603A (en) | Feed composition for immunity comprising extract from yeast, food composition for immunity comprising extract from yeast and manufactuaring method for extract from yeast using ultrasonics wave | |
KR20200137877A (en) | A composition for enhancing immunity comprising the compound isolated from black ginseng extract and black ginseng as an active ingredient for companion dog | |
KR101422673B1 (en) | Composition containing complex extracts for prevention or treatment of colitis | |
KR101624293B1 (en) | Composition for enhancing immune response comprising extract of Benincasa hispida Cogniaux or fermented extract of the same | |
KR101526467B1 (en) | Composition containing Cornus fruit extracts, fractions thereof or compounds isolated therefrom for prevention or treatment of colitis | |
KR101074348B1 (en) | Anti-helicobacter composition containing green algae extract | |
KR102182507B1 (en) | A composition for immune enhancement comprising microsized component of Grifola frodosa | |
KR101853701B1 (en) | Compositions with bioconversion Sesamum indicum for improvement of immunity, diabetes, hyperlipemia or protection against liver damage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |